Onno Faber

Possibility thinker, designer, builder, entrepreneur, rare disease advocate, keynote speaker

[Onno Faber @onnofaber]

My TEDx talk is online!

[Signals @TEDAISF]

More #TEDxSanFrancisco 2019 talks live , check the very personal talk from Onno Faber with “We will all be patients one day” @onnofaber https://t.co/SsNWSOu8RO

[Transcripta Bio @transcriptabio]

🌟 An update on our exciting progress in learning and predicting the effects of small molecules on the transcriptome! 🌟

https://t.co/sq80h1pniL

[Transcripta Bio @transcriptabio]

Characterizing collections of molecules is an important chemoinformatics task. Beyond annotating molecules by common descriptors, can we gain insight by leveraging LLMs for initial triage? Our prototype app, MolSifter, does just that!

[Transcripta Bio @transcriptabio]

We were honored to invite @ashleevance to Transcripta Bio to share our story and how we are charting a faster path in drug discovery to create better lives for people around the world.

https://t.co/SrsHeB62Xr

[Transcripta Bio @transcriptabio]

Neurodevelopmental disorders make up 77% of our current drug discovery portfolio.

This National Developmental Disabilities Awareness Month, let's champion support & inclusion for affected individuals with the rare disease community. #DDAM2023

[proto.life @protolifemedia]

“These things don’t have to be lonely crusades, but they are. Everyone is on their own right now.”

@onnofaber and @rarebasepbc are a mission to remake the dysfunctional rare disease research space.

#RareDiseaseDay #RareDiseaseDay2023
https://t.co/bS5gDLgP2w

[Mike Graglia 🌻 @JMGraglia]

Wonderful & strange to look at the neurons of my two sons👨‍👨‍👦‍👦 (#SYNGAP1🧬 Variant & Wild Type) side by side on a plate. Thank you @rarebasepbc, @onnofaber, @omidkarkouti & @cureSYNGAP1 for making this possible.

Three more lines to go!

💊#Repurposing #RareDiseases #TherapiesNow

[Transcripta Bio @transcriptabio]

Tomorrow is International Day of Women and Girls in Science 🧬🔬🚀

We are grateful to all the women on the Rarebase team for your tireless work to foster partnerships with patient organizations and drive our precision medicine research forward for the #raredisease community.

[Onno Faber @onnofaber]

@TESSResearch @KIF1A @TheatrePresidio @ChanZuckerberg @iamalsorg So moved by this film. Thank you to everyone involved. Patients making a difference. 🙏

[Transcripta Bio @transcriptabio]

Our #precisionmedicine platform Function identifies #drugrepurposing candidates that have the potential to target the root cause biology of rare genetic diseases. Discover how we identify these candidates based on common types of genetic variants: https://t.co/f89Q577kHL

[Onno Faber @onnofaber]

Honored to be working with @cureSYNGAP1 on drug discovery for SYNGAP1 related disorders with @rarebasepbc. Thanks @JMGraglia and @SYNGAP1mom for all you do for the community!

[CURE SYNGAP1 aka SynGAP Research Fund 501(C)(3) @cureSYNGAP1]

Read & share this @Newsweek story profiling SRF, our founders (@SYNGAP1mom & @JMGraglia) and Tony's diagnostic journey.

https://t.co/eyWvSifnaL

FYI @StanfordChild @IDreamofGenes @Invitae @Labcorp (MNG)

[Transcripta Bio @transcriptabio]

Next week our CSO, Chris Moxham, PhD, will give a showcase talk titled “Accelerating a Path Forward for #RareDisease #DrugDiscovery” @PMWCintl on January 27, 2023 in Santa Clara, CA.

We are excited to share our insights on scalable approaches for precision medicine #PMWC23

[Allan Golston @AllanGolston]

"Life's most persistent and urgent question is, 'What are you doing for others?’”

It’s a simple and profound idea from Dr. Martin Luther King, Jr., that inspires and motivates me this #MLK day.

[proto.life @protolifemedia]

“These things don’t have to be lonely crusades, but they are. Everyone is on their own right now.”

@onnofaber and @rarebasepbc are a mission to remake the dysfunctional rare disease research space.

https://t.co/tTyYwmn3Rb

[Transcripta Bio @transcriptabio]

Clayton Mellina (@pumpikano), our Director of Software Engineering, uses breakthrough technologies to drive precision medicine research for rare diseases. Learn more about engineering and AI in the biotech space in our latest episode of Rarebase Remarks: https://t.co/rfCcXh2kbZ

[Transcripta Bio @transcriptabio]

Happy Holidays from all of us here at Rarebase! Thank you to all of our collaborators for your trust and support.

We’re entering the new year with hope and excitement, and together we will relentlessly continue to create a path forward for people affected by rare disease. 🚀

[proto.life @protolifemedia]

“These things don’t have to be lonely crusades, but they are. Everyone is on their own right now.”

@onnofaber and @rarebasepbc are a mission to remake the dysfunctional rare disease research space.

https://t.co/tTyYwmn3Rb

[Onno Faber @onnofaber]

We are honored at @rarebasepbc to be working with so many patient communities to create a path forward to find therapies for rare genetic diseases.

Thanks to HOPE4HARPER (https://t.co/vmYkGJW3aC) for enabling our work on #CDKL5 related disorders.

[Transcripta Bio @transcriptabio]

A new article by @illumina shares Jainu and Shruti Jogani’s quest to find therapeutic opportunities for their daughter, Reyna, who is affected by CDKL5 deficiency disorder. The Rarebase Function™ platform is helping to advance their search.
https://t.co/abCMUL3n9O

[Transcripta Bio @transcriptabio]

Last week our Co-Founder and CEO @onnofaber presented on "Precision Medicine for Rare Genetic Diseases" at the Rare Entrepreneur Bootcamp hosted by @ultragenyx.

As always, this event serves as a reminder of the power of collaboration as we search for solutions for rare diseases.

[Transcripta Bio @transcriptabio]

Congratulations to the #CannonballRun team -- they completed 2,906 miles in 2 days 9hrs & raised over $112k to fund #SYNGAP1 research! Read more below.

[Transcripta Bio @transcriptabio]

Good luck to the #CannonballForACure team as they raise funds for #SYNGAP1 research! Our co-founders Onno Faber and Omid Karkouti will call in to the livestream tomorrow at 11am PST -- join here: https://t.co/oQvRMYDb7F 🛣️🧬🚀